NERISONE

This brand name is authorized in Germany, France, Hong Kong, New Zealand, United Kingdom, South Africa

Active ingredients

The drug NERISONE contains one active pharmaceutical ingredient (API):

1 Diflucortolone UNII 1A63Z067C8 - DIFLUCORTOLONE VALERATE

Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. Read about Diflucortolone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NERISONE Cream, Ointment	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC06	Diflucortolone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00247315, 00247338, 00247545, 00247893, 07548273, 07548296
Country: FR	Base de données publique des médicaments	Identifier(s): 62017113, 63420875, 67945482
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 25698, 38360, 38367, 39616, 39623
Country: HK	Department of Health Drug Office	Identifier(s): 43570
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2372
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/13.4.1/218, H/13.4.1/219, H/13.4.1/220, R/13.4.1/26, R/13.4.1/27